Furosemide, a blocker of Na + /K + /2Cl -cotransporter (NKCC), is often used as a diuretic to improve edema, ascites, and pleural effusion of patients with cancers. The aim of the present study was to investigate whether an NKCC blocker affects cancer cell growth. If so, we would clarify the mechanism of this action. We found that poorly differentiated gastric adenocarcinoma cells (MKN45) expressed the mRNA of NKCC1 three times higher than moderately differentiated ones (MKN28) and that the NKCC in MKN45 showed higher activity than that in MKN28. A cell proliferation assay indicates that furosemide significantly inhibited cell growth in MKN45 cells, but not in MKN28 cells. Using flow cytometrical analysis, we found that the exposure to furosemide brought MKN45 cells to spend more time at the G 0 /G 1 phase, but not MKN28 cells. Based on these observations, we indicate that furosemide diminishes cell growth by delaying the G 1 -S phase progression in poorly differentiated gastric adenocarcinoma cells, which show high expression and activity of NKCC, but not in moderately differentiated gastric adenocarcinoma cells with low expression and NKCC activity.Key words: gastric cancer cell, Na + /K + /2Cl -cotransporter (NKCC), furosemide, cell cycle, cell proliferation.In the past two decades, many researchers have reported the characteristics of ion channels/transporters in various types of cells, including cancer cells. Several types of K + , Ca 2+ , and Cl -channels have been identified in colorectal, breast, lung, and prostate cancer cells [1,2]. Some studies indicate that the transepithelial ion transport plays an important role in cell apoptosis [3,4]. Particularly, the modulation of Cl -transport via Cl -channel, K + /Cl -cotransporter (KCC), and Na + /K + /2Cl -cotransporter (NKCC) occurs in cell proliferation [5][6][7]. However, it is unknown whether NKCC affects the proliferation of cancer cells. In the treatment of patients with terminal stage cancers, however, furosemide (an NKCC blocker, a loop diuretic) is often used as a diuretic to keep urine output and to improve edema, ascites, or pleural effusion. Therefore we performed the present study to clarify the effect of furosemide on the proliferation of cancer cells.In the present study, we used two human gastric cancer cell lines, MKN28 and MKN45, which were established from moderately and poorly differentiated adenocarcinoma, respectively [8]. We determined the mRNA and functional expression levels of the NKCC and investigated the inhibitory effect of an NKCC blocker, furosemide, on the proliferation in these two cancer cell lines. We found that mRNA and the functional expression levels of NKCC were both higher in MKN45 than in MKN28 cells. Furthermore, furosemide diminished the cell proliferation, delaying the G 1 -S phase progression in MKN45 cells, but not in MKN28 cells.
MATERIALS AND METHODSCell culture. The moderately differentiated human gastric adenocarcinoma cell line, MKN28, and the poorly differentiated human gastric adenocarcinoma cel...